AHNAK2 and adenocarcinoma: Sh#2-AHNAK2 was selected for subsequent xenograft assay as it was more effective.In vivo, two cell lines derived xenograft (CDX) models were used to study the role of AHNAK2 in adenocarcinoma tumor progression.